Form 4: Director O'Connor Acquires LMAT Shares

Lemaitre Vascular Director John James O'Connor acquired 10 shares of common stock through the vesting of dividend equivalent rights.

Summary

• John James O'Connor, a Director of Lemaitre Vascular Inc. (LMAT), acquired 10 shares of common stock.
• The acquisition occurred on December 12, 2025, and was a result of the release of dividend equivalent rights.
• These dividend equivalent rights were connected to the vesting of a restricted stock unit award and a performance stock unit award, both originally granted on December 12, 2022.
• The shares were acquired at a price of $0 per share, as is typical for vesting equity awards.
• Following these transactions, Mr. O'Connor directly beneficially owns 62,350 shares of Lemaitre Vascular Inc. common stock.

Sentiment

Score: 6

Explanation: The acquisition of shares by a director, even through compensation vesting, generally indicates continued alignment of interests with shareholders, which is a slightly positive signal.

Positives

• The acquisition of shares by a director, even through compensation vesting, generally indicates continued alignment of interests with shareholders.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance.

Industry Context

This Form 4 reports a routine insider transaction related to director compensation, which does not provide specific insights into broader industry trends or competitive landscape.

Related Party Transactions

• The acquisition of shares by Director John James O'Connor through the vesting of equity awards represents a compensation-related transaction between a related party (director) and the issuer.

Stakeholder Impact

• Shareholders: Minor positive impact due to increased insider ownership, aligning director interests further with shareholder value.

Key Dates

Recommendation

This Form 4 reports a routine acquisition of shares by a director through the vesting of compensation awards. While it increases insider ownership, it does not reflect an open market purchase or significant new information to alter an investment thesis, thus a 'hold' recommendation is appropriate.

Keywords

Lemaitre Vascular, LMAT, John James O'Connor, Form 4, Insider Transaction, Stock Acquisition, Dividend Equivalent Rights, Restricted Stock Units, Performance Stock Units, Director Compensation